Saltar al contenido
Merck

The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors.

Clinical immunology (Orlando, Fla.) (2010-09-14)
Fan Jiang, Wei Chen, Kejia Yi, Zhiqiang Wu, Yiling Si, Weidong Han, Yali Zhao
RESUMEN

Four catechins with the galloyl moiety, including catechin gallate (CG), epigallocatechin gallate (EGCG), gallocatechin gallate (GCG), and epicatechin gallate (ECG), were found to inhibit HIV-1 integrase effectively as determined by our ELISA method. In our docking study, it is proposed that when the HIV-1 integrase does not combine with virus DNA, the four catechins may bind to Tyr143 and Gln148, thus altering the flexibility of the loop (Gly140-Gly149), which could lead to an inhibition of HIV-1 integrase activity. In addition, after combining HIV-1 integrase with virus DNA, the four catechins may bind between the integrase and virus DNA, consequently, disrupt this interaction. Thus, the four catechins may reduce the activity of HIV-1 integrase by disrupting its interaction with virus DNA. The four catechins have a highly cooperative inhibitory effect (IC₅₀=0.1 μmol/L). Our study suggests that catechins with the galloyl moiety could be a novel and effective class of HIV-1 integrase inhibitors.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
(−)-Catechin gallate, ≥98% (HPLC), from green tea
Sigma-Aldrich
(−)-Gallocatechin gallate, from green tea, ≥98% (HPLC)